Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
<h4>Background</h4>The pancreatitis-associated protein (PAP) is increased in the serum of active inflammatory bowel disease (IBD) patients and its levels seem to be correlated with disease activity. Our aim was to evaluate the usefulness of serum and fecal PAP measurements to predict rel...
Enregistré dans:
Auteurs principaux: | Tiago Nunes, Maria Josefina Etchevers, Maria Jose Sandi, Susana Pinó Donnay, Teddy Grandjean, Maria Pellisé, Julián Panés, Elena Ricart, Juan Lucio Iovanna, Jean-Charles Dagorn, Mathias Chamaillard, Miquel Sans |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e0389dc42bc54270b8afa3f8f79ed991 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Metalloproteinases in Inflammatory Bowel Diseases
par: Marônek M, et autres
Publié: (2021) -
Seminars in inflammatory bowel disease
Publié: (2001) - Inflammatory Bowel Disease Monitor
-
MSC therapy for inflammatory bowel disease
par: Mikhail A. Konoplyannikov, et autres
Publié: (2021) -
Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review
par: Laila Aldars-García, et autres
Publié: (2021)